SAM
BMY.RT

Seelaus Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Seelaus Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Hold
0
– – – 196
2020
Q3 		– Hold
0
– – – 153
2020
Q2 		– Sell
-54,254
Closed -$196K – 133
2020
Q1 		$206K Sell
54,254
-150
-0.3% -$494 0.24% 109
2019
Q4 		$164K Buy
+54,404
New +$141K 0.13% 153

Other funds holding BMY.RT

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Seelaus Asset Management's BMY.RT Position: Q4 2020 in Review

Seelaus Asset Management held its Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) position steady in Q4 2020 at 0 shares worth $27K. The position accounts for 0.02% of the portfolio, ranked #196.

Seelaus Asset Management first reported a position in BMY.RT in Q4 2019 and has held it in 2 quarters since. The position peaked at $206K in Q1 2020. 546 funds tracked by Wall St. Rank hold BMY.RT as of Q4 2020.

  • Seelaus Asset Management held 0 shares of Bristol-Myers Squibb Company Contingent Value Rights worth $27K as of Q4 2020.
  • Seelaus Asset Management left its Bristol-Myers Squibb Company Contingent Value Rights share count unchanged in Q4 2020.
  • Bristol-Myers Squibb Company Contingent Value Rights made up 0.02% of Seelaus Asset Management's portfolio in Q4 2020, its #196 holding.
  • Seelaus Asset Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and has held it in 2 quarters since.
  • Seelaus Asset Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $206K in Q1 2020.
  • 546 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q4 2020.

Based on Seelaus Asset Management's 13F filing for Q4 2020, filed 8 Feb 2021.